These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35730322)

  • 1. Relevance of emerging metabolomics-based biomarkers of prostate cancer: a systematic review.
    Bansal N; Kumar M; Sankhwar SN; Gupta A
    Expert Rev Mol Med; 2022 Jun; 24():e25. PubMed ID: 35730322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prostate cancer tissue metabolomics: would clinics utilise it for diagnosis?
    Bansal N; Kumar M; Sankhwar SN; Gupta A
    Expert Rev Mol Med; 2023 Aug; 25():e26. PubMed ID: 37548191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.
    Kumar D; Gupta A; Mandhani A; Sankhwar SN
    Prostate; 2016 Sep; 76(12):1106-19. PubMed ID: 27197810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-to-Date Imaging and Diagnostic Techniques for Prostate Cancer: A Literature Review.
    Zhu M; Liang Z; Feng T; Mai Z; Jin S; Wu L; Zhou H; Chen Y; Yan W
    Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics Biomarkers of Prostate Cancer: A Systematic Review.
    Kdadra M; Höckner S; Leung H; Kremer W; Schiffer E
    Diagnostics (Basel); 2019 Feb; 9(1):. PubMed ID: 30791464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes.
    Salciccia S; Capriotti AL; Laganà A; Fais S; Logozzi M; De Berardinis E; Busetto GM; Di Pierro GB; Ricciuti GP; Del Giudice F; Sciarra A; Carroll PR; Cooperberg MR; Sciarra B; Maggi M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status.
    Dudka I; Thysell E; Lundquist K; Antti H; Iglesias-Gato D; Flores-Morales A; Bergh A; Wikström P; Gröbner G
    BMC Cancer; 2020 May; 20(1):437. PubMed ID: 32423389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics of prostate cancer: Knock-in versus knock-out prostate.
    Kumar D; Bansal N; Gupta A; Mandhani A; Lal H; Kumar M; Sankhwar SN
    J Pharm Biomed Anal; 2021 Oct; 205():114333. PubMed ID: 34461489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive urine metabolomics of prostate cancer and its therapeutic approaches: a current scenario and future perspective.
    Kumar D; Nath K; Lal H; Gupta A
    Expert Rev Proteomics; 2021 Nov; 18(11):995-1008. PubMed ID: 34821179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of patients with and without prostate cancer using urine
    Hasubek AL; Wang X; Zhang E; Kobus M; Chen J; Vandergrift LA; Kurreck A; Ehret F; Dinges S; Hohm A; Tilgner M; Buko A; Habbel P; Nowak J; Mercaldo ND; Gusev A; Feldman AS; Cheng LL
    Magn Reson Chem; 2023 Dec; 61(12):740-747. PubMed ID: 37654196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics-derived prostate cancer biomarkers: fact or fiction?
    Kumar D; Gupta A; Mandhani A; Sankhwar SN
    J Proteome Res; 2015 Mar; 14(3):1455-64. PubMed ID: 25609016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
    Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
    BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic biomarkers of prostate cancer.
    Häggarth L; Hägglöf C; Jaraj SJ; Wester K; Pontén F; Ostman A; Egevad L
    Scand J Urol Nephrol; 2011 Feb; 45(1):60-7. PubMed ID: 21034352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
    Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
    Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate biopsy evolution and the need for repeat biopsy - The role of image and new prostate cancer biomarkers.
    Gil-Sousa D; Oliveira-Reis D; Tavares C; Teves F; Osório L; Gomes M; Soares J; Fraga A
    Arch Esp Urol; 2019 Sep; 72(7):677-689. PubMed ID: 31475679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliable identification of prostate cancer using mass spectrometry metabolomic imaging in needle core biopsies.
    Morse N; Jamaspishvili T; Simon D; Patel PG; Ren KYM; Wang J; Oleschuk R; Kaufmann M; Gooding RJ; Berman DM
    Lab Invest; 2019 Oct; 99(10):1561-1571. PubMed ID: 31160688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR-based metabolomics studies of human prostate cancer tissue.
    Lima AR; Pinto J; Bastos ML; Carvalho M; Guedes de Pinho P
    Metabolomics; 2018 Jun; 14(7):88. PubMed ID: 30830350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
    Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of metabolomics to prostate cancer.
    Trock BJ
    Urol Oncol; 2011; 29(5):572-81. PubMed ID: 21930089
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.